Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth Brambilla

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
The American Journal of Surgical Pathology|May 16, 2006
Pathologic findings of lung tumors diagnosed on baseline CT screeningDouglas B Flieder, Madeline Vazquez, Darryl Carter, et al.
Cancer Genomics & Proteomics|August 10, 2019
Establishment and Validation of Quantitative Real-time PCR Assay for Aberrant Methylation of <i>14-3-3σ</i> Gene in Breast and Lung CarcinomaUbaradka G Sathyanarayana, Makoto Suzuki, Shinichi Toyooka, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2008
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implicationsMadeline Vazquez, Darryl Carter, Elizabeth Brambilla, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2007
Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screeningDarryl Carter, Madeline Vazquez, Douglas B Flieder, et al.
Cancer Biology & Therapy|August 13, 2002
Differential inactivation of caspase-8 in lung cancersNarayan Shivapurkar, Shinichi Toyooka, Michael T Eby, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapyFrances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinomaLouise Burke, Douglas B Flieder, Donald G Guinee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
The American Journal of Surgical Pathology|May 16, 2006
Pathologic findings of lung tumors diagnosed on baseline CT screeningDouglas B Flieder, Madeline Vazquez, Darryl Carter, et al.
Cancer Genomics & Proteomics|August 10, 2019
Establishment and Validation of Quantitative Real-time PCR Assay for Aberrant Methylation of <i>14-3-3σ</i> Gene in Breast and Lung CarcinomaUbaradka G Sathyanarayana, Makoto Suzuki, Shinichi Toyooka, et al.
Lung Cancer (Amsterdam, Netherlands)|October 28, 2008
Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implicationsMadeline Vazquez, Darryl Carter, Elizabeth Brambilla, et al.
Lung Cancer (Amsterdam, Netherlands)|January 24, 2007
Comparison of pathologic findings of baseline and annual repeat cancers diagnosed on CT screeningDarryl Carter, Madeline Vazquez, Douglas B Flieder, et al.
Cancer Biology & Therapy|August 13, 2002
Differential inactivation of caspase-8 in lung cancersNarayan Shivapurkar, Shinichi Toyooka, Michael T Eby, et al.
Clinical Lung Cancer|July 12, 2023
Association of Molecular Profiles and Mutational Status With Distinct Histological Lung Adenocarcinoma Subtypes. An Analysis of the LACE-Bio DataPrashanth Ashok Kumar, Maryam Karimi, Alina Basnet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 2017
Pooled Analysis of the Prognostic and Predictive Effects of TP53 Comutation Status Combined With KRAS or EGFR Mutation in Early-Stage Resected Non-Small-Cell Lung Cancer in Four Trials of Adjuvant ChemotherapyFrances A Shepherd, Benjamin Lacas, Gwénaël Le Teuff, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 2, 2022
Predictive Biomarkers for Immunotherapy in Lung Cancer: Perspective From the International Association for the Study of Lung Cancer Pathology CommitteeMari Mino-Kenudson, Kurt Schalper, Wendy Cooper, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 27, 2005
Prognostic implications of molecular and immunohistochemical profiles of the Rb and p53 cell cycle regulatory pathways in primary non-small cell lung carcinomaLouise Burke, Douglas B Flieder, Donald G Guinee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2013
Pooled analysis of the prognostic and predictive effects of KRAS mutation status and KRAS mutation subtype in early-stage resected non-small-cell lung cancer in four trials of adjuvant chemotherapyFrances A Shepherd, Caroline Domerg, Pierre Hainaut, et al.
Pageof 3